Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China · Delayed Price · Currency is CNY 10.92
-0.18 (-1.62%)
Sep 10, 2026, 2:45 PM CST
SHE:002923 Revenue
Zhuhai Rundu Pharmaceutical had revenue of 360.18M CNY in the quarter ending June 30, 2026, with 22.78% growth. This brings the company's revenue in the last twelve months to 1.34B, up 17.99% year-over-year. In the year 2025, Zhuhai Rundu Pharmaceutical had annual revenue of 1.18B, down -0.51%.
Revenue (ttm)
1.34B
Revenue Growth
+17.99%
P/S Ratio
2.78
Revenue / Employee
807.96K
Employees
1,655
Market Cap
3.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.18B | -6.00M | -0.51% |
| Dec 31, 2024 | 1.18B | -109.52M | -8.48% |
| Dec 31, 2023 | 1.29B | -80.35M | -5.86% |
| Jan 1, 2023 | 1.37B | 182.31M | 15.32% |
| Jan 1, 2022 | 1.19B | -62.70M | -5.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Starry Pharmaceutical | 2.46B |
| Tibet Weixinkang Medicine | 1.13B |
| Harbin Medisan Pharmaceutical | 805.09M |
| Shandong Wohua Pharmaceutical | 784.94M |
| Nanjing Hicin Pharmaceutical | 726.62M |
| Shaanxi Kanghui Pharmaceutical | 429.09M |
| Lionco Pharmaceutical Group | 408.33M |
| Hainan Shuangcheng Pharmaceuticals | 309.80M |